FDMDF (4DMedical) Accounts Receivable: $0.89 Mil (As of Dec. 2025)


FDMDF 4DMedical Ltd FDMDF
46 GF Score
Price $2.80
GF Value $0.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Accounts Receivable?

4DMedical FDMDF -6.67% 46 Accounts Receivable is $0.89 Mil as of Dec. 2025. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. 4DMedical's accounts receivables for the quarter that ended in Dec. 2025 was $0.89 Mil.

Accounts receivable can be measured by Days Sales Outstanding. 4DMedical's Days Sales Outstanding for the quarter that ended in Dec. 2025 was 87.23.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. 4DMedical's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was $-0.14.

4DMedical Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

4DMedical's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.89/1.862*91
=87.23

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), 4DMedical's accounts receivable are only considered to be worth 75% of book value:

4DMedical's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(37.716+0.75 * 0.89+0.5 * 0.611-111.596
-0-0)/534.167
=-0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

4DMedical Accounts Receivable Related Terms

4DMedical Accounts Receivable Historical Data

* Premium members only.

The historical data trend for 4DMedical's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4DMedical Accounts Receivable Chart

4DMedical Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Receivable
Get a 7-Day Free Trial 0.33 1.51 0.39 0.84 0.78

4DMedical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.84 0.68 0.78 0.89
FDMDF
46GF Score
4DMedical Ltd FDMDF
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4DMedical Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of $0.89 Mil mean?
4DMedical (FDMDF) has a Accounts Receivable of $0.89 Mil as of Dec. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on 4DMedical and its competitors.
Is 4DMedical's Accounts Receivable too high?
4DMedical's current Accounts Receivable is $0.89 Mil. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Accounts Receivable compare to ABT and SYK?
4DMedical's Accounts Receivable of $0.89 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Medical Devices & Instruments company?
A good Accounts Receivable depends on the Medical Devices & Instruments industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on 4DMedical and its competitors. 4DMedical's current Accounts Receivable is $0.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current Accounts Receivable is $0.89 Mil. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Accounts Receivable is $0.89 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4DMedical (FDMDF) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FDMDF:

  • Accounts Receivable: $0.89 Mil
  • GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4DMedical Business Description

Other Exchanges MQ7:Germany4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score

Get the complete analysis for FDMDF

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.80
Price
$0.87
GF Value